Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: U54CA224083
National Cancer Institute
Grant: P50CA174521
National Institutes of Health
Grant: T32CA148062
National Institutes of Health
Grant: 1S10OD026835-01
IVIS Biolumenscence and Fluorescence Live Animal Imaging
National Institutes of Health
Grant: 3T32CA148062-04S1
University of Iowa Surgical Oncology Research Training Program
National Institutes of Health
Grant: 3U54CA224083-04S1
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models
National Institutes of Health
Grant: 3P50CA174521-05S3
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
NCI NIH HHS
Grant: P30 CA091842
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals